This inventor holds 1 USPTO granted patent. Top assignee: Theravance Biopharma R&d IP, LLC. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Jens Maes: Innovator in Pharmaceutical Compositions
Introduction
Jens Maes is a notable inventor based in Herentals, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work is characterized by a focus on creating effective treatments for various medical conditions.
Latest Patents
Jens Maes holds 1 patent for his invention titled "Formulation of a pan-JAK inhibitor." This patent relates to pharmaceutical compositions that include a specific compound, which has potential applications in treating various diseases. The formulation details methods of use and preparation, showcasing his expertise in pharmaceutical sciences.
Career Highlights
Throughout his career, Jens has been associated with Theravance Biopharma R&D IP, LLC, where he has contributed to groundbreaking research and development efforts. His work has been instrumental in advancing the understanding and treatment of complex medical conditions through innovative drug formulations.
Collaborations
Jens Maes has collaborated with esteemed colleagues, including Bernardus Joseph Nitert and Yvonne Rosiaux. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to significant advancements in pharmaceutical innovations.
Conclusion
Jens Maes exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in developing effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile